Startup profile for Bold: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Bold funding, valuation and investors

Digital health platform delivering insurance-covered exercise programs for older adults.

Keep track of Bold

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Seed

$7M · February 2021

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$7M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

seed

Investors in latest funding

Lead: Andreessen Horowitz

Sources: latest funding Last verified: 2026-07-25

Overview

Bold provides virtual exercise and fall-prevention programs for older adults, delivered through a digital health platform and covered by Medicare Advantage and select health plans. Founded to improve mobility and reduce fall risk in seniors, Bold partners with insurers so members access personalized workout plans at no or low out-of-pocket cost. In February 2021 Bold raised a $7M seed round led by Andreessen Horowitz Bio + Health. The company sits in the value-based care trend linking prevention to payer cost savings.

Why Bold is interesting

Bold routes senior fitness through Medicare Advantage — a16z Bio + Health seed bet that movement reduces downstream medical spend.

Product & use cases

At-home and virtual exercise programs tailored for seniors — balance, strength, fall prevention — billed through Medicare Advantage and health plan partnerships.

  • Medicare Advantage members accessing covered fitness programs
  • Fall prevention for aging populations
  • Payer-sponsored digital musculoskeletal prevention

Key facts

  • Seed (Feb 2021): $7M led by a16z Bio + Health (TechCrunch)
  • Medicare Advantage coverage model

Funding history (newest first)

Investors in our directory

Funds linked from Bold's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Insurance reimbursement path for seniors vs. consumer fitness apps like Peloton that don't target MA coverage.

Senior digital health growing as MA plans seek cost offsets. Bold competes with legacy fitness benefits (SilverSneakers) and MSK players. Payer sales cycles are slow but create durable revenue if clinical outcomes hold.

  • SilverSneakers incumbent

    Established senior fitness benefit through health plans.

  • Hinge Health / Sword adjacent

    MSK digital therapeutics; Bold focuses prevention/exercise for seniors broadly.

  • Peloton / consumer fitness alternative

    D2C subscription; not MA-integrated.

Notable stories

  • TechCrunch covered Bold as senior-focused fitness with insurer payment model.
  • a16z Bio + Health led seed aligning prevention with payer economics.

Industries

Healthtech

Related funding articles

Venture Capital Tracker pieces that cover Bold's financing or category context.

FAQs about Bold

Practical answers founders, operators, and investors typically search for.

Digital exercise platform for older adults with programs often covered by Medicare Advantage plans.
a16z Bio + Health led $7M seed February 2021. See /fund/andreessen-horowitz.
Yes — partners with Medicare Advantage and health plans for member access.
SilverSneakers is legacy gym benefit; Bold is digital-first virtual exercise and fall prevention.
February 2021 seed.
Older adults seeking strength, balance, and fall-prevention exercise.
$7M seed disclosed.
United States digital health market; check agebold.com for HQ.
Positioned as wellness/exercise through payer partnerships; check company for regulatory status.
Not publicly disclosed.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.